The present invention relates to catheter-dressing systems with integrated flushing mechanisms and related methods.
During placement of an intravascular catheter, the current standard of care technique includes flushing of the newly inserted catheter with sterile saline solution to clear the hub and catheter of blood that would otherwise coagulate and result in loss of catheter function. Present standard catheter placement and flush methodology involves several separate, often one-handed, sequential steps using non-sterile gloves.
First, the insertion site is prepped with sterilizing solution (e.g., chlorhexidine). Second, using non-sterile gloves, the vascular catheter is inserted through the skin and into the blood vessel, taking care not to touch the actual insertion site or catheter with the non-sterile gloves. Third, with one hand, the insertion needle is withdrawn from the catheter and put aside (e.g., on a bed or side table). During this time, the other hand stabilizes the catheter hub and applies pressure to the blood vessel upstream from the insertion site to prevent back-bleeding. Care must be taken not to touch the insertion site (either the catheter or the surrounding skin) with the non-sterile gloved hand. Fourth, the hand that withdrew the needle then reaches for and obtains from the local area (e.g., bed or side table) an IV hub cap device (e.g., a Luer Lock® connector, a Clave® connector, or extension tubing with attached Clave®), which is placed both to prevent backflow of blood into the catheter and to allow for mechanical connection to, and use of, the catheter. The hub cap device packaging has been pre-opened and set aside within reach to allow one-handed pick up and manipulation of the hub cap during this process.
Fifth, the free hand then reaches for and obtains from the local area (e.g., bed or side table) a syringe that has been pre-filled with sterile saline. Sixth, the syringe is attached to the hub cap device, and the saline solution is injected/flushed into the connection device-catheter complex to displace blood from the catheter into the blood vessel, leaving the catheter filled with saline solution. Seventh, the syringe is detached and put aside. Eighth, and finally, a “sterile” dressing is then placed over the catheter hub and skin insertion site (although often at this point neither the catheter or dressing is sterile, as during the process they have been touched repeatedly by non-sterile gloved fingers). Additional adhesive tape is then applied to further secure and position the catheter.
Wide variations in this process occur, leading consequently to highly-variable results. One common variation is to flush the catheter with saline prior to placing the hub cap device. In other instances, an IV line is attached directly to the hub and IV fluid administration initiated (thereby negating the need for saline flush). In all instances, the technique is awkward, requires the use of multiple complex one-handed maneuvers at multiple time points, and requires use of an often unprepared working area beyond the actual insertion site (e.g., bed or side table)—an area that is usually not sterile/clean.
Looming over this standard vascular catheter insertion process is the desire for sterility and the prevention of outside organisms (e.g., hospital environment bacteria) from reaching the catheter insertion site. While this is the goal, in reality it is extremely difficult to achieve. The complexity of the catheter insertion and flush procedure, combined with the fact that it is done over such a broad and varied working area with non-sterile gloves, leaves multiple points for loss of sterile technique. All too often, the end result of this highly complex and variable process is a non-sterile catheter and catheter insertion site. This lack of sterility is compounded over time by the placement of a non-sealing dressing that cannot maintain sterility even if it is able to be achieved initially. The result is the increased loss of catheters from site infection, and the need to change catheters and dressings at relatively frequent intervals in hopes of preventing clinical expression of catheter infection. One very clear marker of the inadequacy of existing catheter insertion-dressing placement technique is the increasing reliance on compensatory measures such as antimicrobial adjuncts and supplementary securement devices.
Accordingly, a need exists for improved methods and devices for sterile placement and maintenance of catheters.
Methods and devices are disclosed herein that generally involve a sterile catheter-dressing system that allows for integrated injection of a fluid, e.g., a saline flush, during the process of catheter insertion and sterile dressing placement. Such methods and devices greatly simplify the catheter insertion process, and allow the reproducible placement of a fully sterile and flushed vascular catheter, as well as the placement of a durably sterile circumferentially sealing and securing dressing.
With such methods and devices, the sterile saline catheter flush process can be simply and efficiently integrated with the processes of catheter placement and catheter dressing placement. In one embodiment, a device is provided that utilizes a needle containment device already attached to the catheter hub during catheter insertion not only as a handle for mounting and placement of a sterile dressing, but also to contain and inject sterile saline into the inserted catheter. In some embodiments, by incorporating the saline flush capability into the needle containment device, the needle containment device's “natural” pre-attached position relative to the catheter can be taken advantage of, allowing marked simplification of the saline flush process. Multiple awkward one-handed maneuvers are avoided, thereby eliminating multiple potential sterility breakpoints. Effort is fully and simply concentrated on the catheter and its pre-attached needle containment device, without the need for reaching for/utilizing non-sterile side work areas. Using these methods and devices, the use of sterile gloves becomes possible, and can be easily made routine, representing a true paradigm shift in vascular catheter placement and care.
The integrated system can also include a circumferentially sealing dressing configured to mount over the needle containment device which contains the saline flush, and into final mating/sealing position on the catheter hub.
Methods and devices are also disclosed herein which allow integrated sterile flushing of existing catheters and connection device technology (e.g., a Luer Lock® connector, or a Clave® connector) as well as simple and sterile placement of a circumferential sealing dressing. For example, in one embodiment, saline-containing tubular bodies of specified relative diameter are provided which can be pre-attached to hub cap devices (e.g., Luer Lock® connector, Clave® connector). These hub cap devices can be coupled to existing standard catheters, allowing the tubular body to be used as a “handle” to allow easy and sterile control when mounting the hub cap device to the inserted catheter hub and when subsequently attaching a sterile circumferentially-sealing dressing. In other words, the sterile flush handle can serve a dual purpose as a mounting device, whereby the circumferentially sealing dressing is slid over the handle and mounted into position on the hub cap device. Once the tubular body is attached to the catheter, injection of the saline through the attached hub cap device and through the inserted catheter to clear any contained blood then naturally follows in simple sterile fashion, without the need for reaching for and attaching a separate saline flush syringe. In some embodiments, the sterile sealing dressing can also be integrated with the hub cap device, in which case the dressing can simply be “unfurled” after the saline flush is complete. The dressing can then be adhered to the skin around the catheter insertion site. Detachment of the saline filled mounting tube completes the process.
Incorporation of the saline flush into the needle containment device, or into a saline body attached to a hub cap device, leads to a significant improvement and simplification of the catheter insertion, catheter flushing, and dressing placement processes. It allows concentration of effort at a single point, and allows these processes to be performed in a more sterile fashion. In addition, a durable and fully-sterile circumferentially sealing dressing can be placed in conjunction with existing vascular catheter technology. In some embodiments, the needle containment device preferably has a diameter that is equal to or less than that of the catheter hub, thereby allowing a sterile sealing dressing to be slid down over the needle containment device and mounted to the catheter hub in sealing engagement.
In one aspect, a catheter system is provided that includes a catheter assembly comprising an implantable catheter and catheter hub formed at a proximal end of the implantable catheter. The system also includes a needle containment device extending proximally from the catheter assembly, the needle containment device being coupled to an insertion needle disposed through an inner lumen of the implantable catheter. The needle containment device includes a chamber filled with an injectable agent and is configured to selectively place the chamber in fluid communication with the inner lumen of the implantable catheter.
The system can also include a dressing assembly configured to slide over the needle containment device and catheter hub to form a circumferential seal around the catheter hub and a catheter insertion site. The injectable agent can include sterile saline or other solution suitable for flushing a catheter. The chamber can include a flexible bag. The needle containment device can include a first hemi-cylindrical collar disposed about an exterior surface of a body portion of the needle containment device, the collar being coupled to a roller configured to compress the chamber. Sliding the first collar distally relative to the body portion can cause the roller to compress the chamber and force the injectable agent into the inner lumen of the implantable catheter. The needle containment device can include a second hemi-cylindrical collar disposed about an external surface of a body portion of the needle containment device, the collar being coupled to the insertion needle. Sliding the second collar proximally relative to the body portion can be effective to withdraw the insertion needle from the implantable catheter and into the needle containment device.
The needle containment device can include a valve that controls fluid communication between the chamber and the inner lumen of the implantable catheter. The insertion needle can block an aperture of the valve when the insertion needle is in a deployed configuration. The aperture of the valve can be open when the insertion needle is in a retracted configuration. The needle containment device can have a maximum outer diameter that is less than or equal to a diameter of a mating point on the catheter assembly to which a dressing can be mated. A circumferentially-sealing catheter dressing is adapted to be slid over the needle containment device.
The needle containment device can be divided into two or more separate compartments, at least one compartment being filled with the injectable agent. The needle containment device can include a sliding collar whose movement distally towards the catheter assembly effects pressure based transfer of the injectable agent from the chamber into the catheter assembly. The needle containment device can include a central plunger, proximal withdrawal of the plunger out of the needle containment device can serve to remove the insertion needle from the implantable catheter and lock it into a retracted position, and subsequent distal movement of the plunger can serve to effect transfer of the injectable agent from the chamber to the catheter assembly.
In another aspect, a catheter flushing device is provided that includes an elongate body portion defining a fluid chamber therein, a coupling element at a distal end of the body portion configured to couple the body portion to a catheter assembly such that the fluid chamber can be selectively placed in fluid communication with a lumen of the catheter assembly, and an actuator configured to expel a fluid from the fluid chamber and into a lumen of a catheter assembly to which the device is coupled.
The fluid can include sterile saline. The catheter assembly can include at least one of a catheter, a catheter hub, a catheter hub cap, a vascular catheter, a custom catheter, and an existing catheter. The device can allow for direct injection of the fluid into the catheter assembly at the time of attachment of the device to the catheter. The catheter flushing device can be pre-attached to the catheter assembly. The coupling element can be configured to couple to conventional catheters or catheter assemblies. The coupling element can include at least one of a Luer Lock® connector, a Clave® connector, and extension tubing. The device can include a circumferentially sealing dressing formed integrally with the coupling element. The coupling element can be or can include a hub cap, and the device can include a circumferentially sealing dressing configured to seal to the hub cap. The body portion can be used as a handle over which a circumferentially sealing dressing can be mounted and attached to the catheter assembly.
In another aspect, a method of placing and flushing a catheter is provided that includes inserting a catheter over an insertion needle into a patient, the catheter having a needle containment device coupled thereto, withdrawing the insertion needle from the catheter into the needle containment device, and transferring a volume of an injectable agent into an inner lumen of the catheter.
The method can include transferring the injectable agent into the inner lumen from a chamber within the needle containment device. The method can include sliding a sterile sealing dressing over the needle containment device and onto the catheter, wherein the needle containment device is sterile. The method can include adhering the dressing circumferentially around the catheter insertion site to create a sterile sealed chamber. The method can include detaching the needle containment device from the catheter or other component of a catheter assembly after adhering the dressing.
The method can include coupling a sterile flushing device having a fluid chamber defined therein to the catheter, actuating the flushing device to force the injectable agent from the fluid chamber into the inner lumen of the catheter, using the flushing device as a sterile handle, sliding a sterile dressing over the flushing device, circumferentially sealing the dressing around a catheter insertion site, and detaching the sterile flushing device from the catheter or other component of a catheter assembly.
The method can include coupling a sterile flushing device having a fluid chamber defined therein to the catheter, actuating the sterile flushing device to force the injectable agent from the fluid chamber into the inner lumen of the catheter, using the flushing device as a sterile handle to control and stabilize the catheter while unfurling and circumferentially adhering a dressing integrated therewith around a catheter insertion site, and detaching the flushing device from the catheter. The method can include adhering the dressing to a portion of the catheter or a catheter assembly.
The invention will be more fully understood from the following detailed description taken in conjunction with the accompanying drawings, in which:
Certain exemplary embodiments will now be described to provide an overall understanding of the principles of the structure, function, manufacture, and use of the devices and methods disclosed herein. One or more examples of these embodiments are illustrated in the accompanying drawings. Those skilled in the art will understand that the devices and methods specifically described herein and illustrated in the accompanying drawings are non-limiting exemplary embodiments and that the scope of the present invention is defined solely by the claims. The features illustrated or described in connection with one exemplary embodiment may be combined with the features of other embodiments. Such modifications and variations are intended to be included within the scope of the present invention.
A person skilled in the art will appreciate that, while methods and devices are described herein in connection with catheters implantable in humans, the methods and devices can also be used in any instance in which a seal is desired around an elongate device implanted into or otherwise extending from a plant, an animal, and/or any non-living machine, structure, or system or in which a flushing capability is desired. In addition, while the methods and devices disclosed herein are described primarily with respect to intravenous catheters, they can also be used with any of a variety of other devices and other procedures including, without limitation, arterial monitoring lines, access sheaths for intravascular procedures such as angiography and stenting, access sheaths for intravascular therapeutic devices such as intra-aortic balloon pumps and ventricular support devices, etc.
Further details on catheter-dressing systems can be found in U.S. Publication No. 2012/0197204, filed on Jan. 13, 2012 and entitled “SNAP-SEAL STERILE INTRAVASCULAR CATHETER-DRESSING SYSTEM,” the entire contents of which are incorporated herein by reference. Further details on catheter-dressing systems can also be found in U.S. Publication No. 2011/0106014, filed on Oct. 28, 2010 and entitled “SEALED STERILE CATHETER DRESSINGS,” the entire contents of which are incorporated herein by reference.
It should be noted that other saline containment and injection actuators can be used, including a vertically collapsible “accordion” actuator or a central plunger actuator (as described below and shown in
In one embodiment, some or all of the following steps can be executed in connection with the system 10 illustrated in
While saline flush handles are disclosed that are specifically configured to couple using Luer Lock® or Clave® type connectors, it will be appreciated that the saline flush handles can be readily adapted to other standard or non-standard connectors.
In one embodiment, some or all of the following steps can be executed in connection with the system illustrated in
In one embodiment, some or all of the following steps can be executed in connection with the system illustrated in
As also shown in
Any of the components of the devices disclosed herein can be transparent or semi-transparent to allow visualization of blood, saline, or other materials contained therein. Any of the needle containment devices disclosed herein can include a lockout feature to lock the needle in the retracted position to facilitate safe removal and disposed. The interior or exterior of any of the components of the devices disclosed herein can be coated and/or impregnated with a sterilizing agent.
The systems described herein can also be packaged in the form of a kit including dressings, catheters, hubs, hub caps, hub protection devices, insertion needles, needle containment devices, and/or other components of various sizes and shapes for use with various sized catheters, patients, body parts, etc. The kit can also include various items for sterile site preparation and sterile catheter insertion, such as tourniquets, preparation solutions, solution applicators, sterile saline flush, and/or sterile gloves. The devices disclosed herein can be designed to be disposed of after a single use, or they can be designed to be used multiple times. In either case, however, the device can be reconditioned for reuse after at least one use. Reconditioning can include any combination of the steps of disassembly of the device, followed by cleaning or replacement of particular pieces, and subsequent reassembly. In particular, the device can be disassembled, and any number of the particular pieces or parts of the device can be selectively replaced or removed in any combination. Upon cleaning and/or replacement of particular parts, the device can be reassembled for subsequent use either at a reconditioning facility, or by a caregiver immediately prior to a catheterization procedure. Those skilled in the art will appreciate that reconditioning of a device can utilize a variety of techniques for disassembly, cleaning/replacement, and reassembly. Use of such techniques, and the resulting reconditioned device, are all within the scope of the present application.
Preferably, the invention described herein will be processed before use. First, a new or used device is obtained and if necessary cleaned. The device can then be sterilized. In one sterilization technique, the instrument is placed in a closed and sealed container, such as a plastic or TYVEK bag. The container and device are then placed in a field of radiation that can penetrate the container, such as gamma radiation, x-rays, or high-energy electrons. The radiation kills bacteria on the device and in the container. The sterilized device can then be stored in the sterile container. The sealed container keeps the device sterile until it is opened in the medical field.
It is preferred that the device is sterilized. This can be done by any number of ways known to those skilled in the art including beta or gamma radiation, ethylene oxide, steam, and/or a liquid bath (e.g., cold soak).
One skilled in the art will appreciate further features and advantages of the invention based on the above-described embodiments. Accordingly, the invention is not to be limited by what has been particularly shown and described, except as indicated by the appended claims. All publications and references cited herein are expressly incorporated herein by reference in their entirety.
This application claims priority to U.S. Provisional Application No. 61/534,981, filed on Sep. 15, 2011, which is hereby incorporated by reference in its entirety. This application is also a continuation-in-part of, and claims priority to, U.S. patent application Ser. No. 13/349,909, filed Jan. 13, 2012 (now U.S. Pat. No. 8,715,242, issued May 6, 2014), which in turn claims the benefit of priority of U.S. Provisional Patent Application No. 61/437,862, filed on Jan. 31, 2011, U.S. Provisional Patent Application No. 61/482,124, filed May 3, 2011, and U.S. Provisional Patent Application No. 61/482,564, filed May 4, 2011.
Number | Name | Date | Kind |
---|---|---|---|
2461891 | Giles | Feb 1949 | A |
3198385 | Maxwell | Aug 1965 | A |
3683911 | McCormick | Aug 1972 | A |
3918446 | Buttaravoli | Nov 1975 | A |
4016879 | Mellor | Apr 1977 | A |
4327723 | Frankhouser | May 1982 | A |
4392853 | Muto | Jul 1983 | A |
4464178 | Dalton | Aug 1984 | A |
4515592 | Frankhouser | May 1985 | A |
4551136 | Mandl | Nov 1985 | A |
4551137 | Osborne | Nov 1985 | A |
4563177 | Kamen | Jan 1986 | A |
4634433 | Osborne | Jan 1987 | A |
4767411 | Edmunds | Aug 1988 | A |
4781695 | Dalton | Nov 1988 | A |
4966590 | Kalt | Oct 1990 | A |
5007901 | Shields | Apr 1991 | A |
5074847 | Greenwell et al. | Dec 1991 | A |
5112313 | Sallee | May 1992 | A |
5116324 | Brierley et al. | May 1992 | A |
5215532 | Atkinson | Jun 1993 | A |
5232453 | Plass et al. | Aug 1993 | A |
5238010 | Grabenkort et al. | Aug 1993 | A |
5336195 | Daneshvar | Aug 1994 | A |
5344415 | DeBusk et al. | Sep 1994 | A |
5372589 | Davis | Dec 1994 | A |
5380294 | Persson | Jan 1995 | A |
5415642 | Shepherd | May 1995 | A |
D359120 | Sallee et al. | Jun 1995 | S |
5478326 | Shiu | Dec 1995 | A |
5577516 | Schaeffer | Nov 1996 | A |
5685865 | Cosgrove et al. | Nov 1997 | A |
5686096 | Khan et al. | Nov 1997 | A |
5690612 | Lopez et al. | Nov 1997 | A |
5694686 | Lopez | Dec 1997 | A |
5702371 | Bierman | Dec 1997 | A |
5707348 | Krogh | Jan 1998 | A |
5715815 | Lorenzen et al. | Feb 1998 | A |
5722959 | Bierman | Mar 1998 | A |
5769807 | Haddock et al. | Jun 1998 | A |
5772636 | Brimhall et al. | Jun 1998 | A |
5776106 | Matyas | Jul 1998 | A |
5807341 | Heim | Sep 1998 | A |
5989220 | Shaw et al. | Nov 1999 | A |
6080138 | Lemke et al. | Jun 2000 | A |
6099509 | Brown, Jr. et al. | Aug 2000 | A |
6132399 | Shultz | Oct 2000 | A |
6302867 | Brown, Jr. et al. | Oct 2001 | B1 |
6375639 | Duplessie et al. | Apr 2002 | B1 |
6413240 | Bierman et al. | Jul 2002 | B1 |
6569121 | Purow et al. | May 2003 | B1 |
6571395 | Korkor | Jun 2003 | B1 |
6809230 | Hancock et al. | Oct 2004 | B2 |
6827707 | Wright | Dec 2004 | B2 |
7083598 | Liska | Aug 2006 | B2 |
7153291 | Bierman | Dec 2006 | B2 |
7244245 | Purow et al. | Jul 2007 | B2 |
7247150 | Bierman | Jul 2007 | B2 |
7544186 | Davis et al. | Jun 2009 | B2 |
7578804 | Bierman | Aug 2009 | B2 |
7723561 | Propp | May 2010 | B2 |
7744572 | Bierman | Jun 2010 | B2 |
7799001 | Bierman | Sep 2010 | B2 |
7806873 | Dikeman et al. | Oct 2010 | B2 |
8414543 | McGuckin et al. | Apr 2013 | B2 |
20020082559 | Chang et al. | Jun 2002 | A1 |
20020092529 | Rozier et al. | Jul 2002 | A1 |
20030078540 | Saulenas et al. | Apr 2003 | A1 |
20040044310 | Suzuki | Mar 2004 | A1 |
20050065479 | Schiller et al. | Mar 2005 | A1 |
20050113798 | Slater et al. | May 2005 | A1 |
20050119619 | Haining | Jun 2005 | A1 |
20050165355 | Fitzgerald | Jul 2005 | A1 |
20050261623 | Propp | Nov 2005 | A1 |
20060030820 | Alheidt et al. | Feb 2006 | A1 |
20060211994 | Roman et al. | Sep 2006 | A1 |
20060247577 | Wright | Nov 2006 | A1 |
20060247582 | Alheidt et al. | Nov 2006 | A1 |
20060264836 | Bierman | Nov 2006 | A1 |
20070027429 | Kuracina et al. | Feb 2007 | A1 |
20070055205 | Wright et al. | Mar 2007 | A1 |
20070060892 | Propp | Mar 2007 | A1 |
20080058692 | Propp et al. | Mar 2008 | A1 |
20080125750 | Gaissert | May 2008 | A1 |
20080221531 | Alheidt et al. | Sep 2008 | A1 |
20080262439 | Alheidt | Oct 2008 | A1 |
20080300574 | Belson et al. | Dec 2008 | A1 |
20090118696 | Nyhart, Jr. | May 2009 | A1 |
20090192470 | Propp | Jul 2009 | A1 |
20090306602 | Elwell et al. | Dec 2009 | A1 |
20090318891 | Marcotte et al. | Dec 2009 | A1 |
20100100049 | Godfrey | Apr 2010 | A1 |
20100179482 | Wright et al. | Jul 2010 | A1 |
20100249706 | Clemente | Sep 2010 | A1 |
20110106014 | Helm, Jr. | May 2011 | A1 |
20120197204 | Helm, Jr. | Aug 2012 | A1 |
20120232489 | Helm, Jr. | Sep 2012 | A1 |
Number | Date | Country |
---|---|---|
3140192 | Apr 1983 | DE |
9405239 | Mar 1994 | WO |
9702848 | Jan 1997 | WO |
2008117078 | Oct 2008 | WO |
Entry |
---|
[No Author Listed] Alibaba.com Product Literature—IV Catheter Dressing (accessed Nov. 17, 2010). |
[No Author Listed] Become.com Product Literature—3m Catheter Dressing (accessed Nov. 17, 2010). |
[No Author Listed] IV Team, BD Announces UK Launch of new BD Nexiva(TM) Closed IV Catheter System Designed to Help Protect Healthcare Workers, PR Newswire.com, Jul. 29, 2009. |
[No Author Listed] Seattle Treatment Education Project, The Body, The Facts About Intravenous Catheter Lines, thebody.com, Oct. 1992. |
[No Author Listed] “Silverlone® Lifesaver198 Ag” 7 Day Antimicrobial IV/Catheter Dressing Product Literature, silverlon.com (accessed Nov. 17, 2010). |
[No Author Listed] Smith & Nephew Product Literature—I.V. and Catheter Sites, smith-nephew.com (accessed Nov. 17, 2010). |
[No Author Listed] Sorbaview Shield Product Literature, centurionmp.com (accessed Nov. 17, 2010). |
[No Author Listed] Walgreens.com Product Literature—Medline Suresite I.V. Transparent Catheter Dressing 2×3 (accessed Nov. 17, 2010). |
Australian Office Action issued Jun. 20, 2012 for Application No. 2010319924 (5 Pages). |
Clemens, Mary, New IV Dressing Benefits Both the Patient and Clinician, Reuters.com, Feb. 2, 2009. |
International Search Report and Written Opinion mailed Jul. 20, 2011 for Application No. PCT/US10/054427. |
International Preliminary Report on Patentability for Application No. PCT/US2010/054427 mailed May 10, 2012 (7 Pages). |
International Search Report and Written Opinion mailed Aug. 17, 2012 for Application No. PCT/US2012/021196 (12 Pages). |
Johnson, Maree, M.D., Systematic Review Central Line Dressing Type and Frequency, Joanna Briggs Institute, Jan. 20, 1998. |
Maki DG, and Ringer M., Evaluation of dressing regimens for prevention of infection with peripheral intravenous catheters. Gauze, a transparent polyurethane dressing, and an iodophor-transparent dressing., JAMA. Nov. 6, 1987;258 (17):2396-403., pubmed.gov. |
McGee, David C, M.D. and Michael K. Gould, M.D., Preventing Complications of Central Venous Catheterization, N. Engl J Med 2003; 348:1123-1133. |
Australian Office Action issued Nov. 1, 2012 for Application No. 2010319924 (3 Pages). |
Supplemental European Search Report mailed Apr. 18, 2013 for Application No. 10830440.3 (7 Pages). |
International Preliminary Report on Patentability and Written Opinion of the International Searching Authority of PCT/US2012/055066, mailed Mar. 27, 2014 (7 pages). |
Number | Date | Country | |
---|---|---|---|
20130178825 A1 | Jul 2013 | US |
Number | Date | Country | |
---|---|---|---|
61534981 | Sep 2011 | US | |
61437862 | Jan 2011 | US | |
61482124 | May 2011 | US | |
61482564 | May 2011 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13349909 | Jan 2012 | US |
Child | 13613509 | US |